161 related articles for article (PubMed ID: 37682190)
1. Analysis of the influence factors of cervical lymph node metastasis in Papillary thyroid carcinoma: A retrospective observational study.
Lou J; Yang J; Luo Y; Zhu Y; Xu Z; Hua T
Medicine (Baltimore); 2023 Sep; 102(36):e35045. PubMed ID: 37682190
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
3. Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Ye L; Hu L; Liu W; Luo Y; Li Z; Ding Z; Hu C; Wang L; Zhu Y; Liu L; Ma X; Kong Y; Huang L
BMC Cancer; 2021 Nov; 21(1):1250. PubMed ID: 34800991
[TBL] [Abstract][Full Text] [Related]
4. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
[TBL] [Abstract][Full Text] [Related]
5. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.
Liu W; Zhang D; Jiang H; Peng J; Xu F; Shu H; Su Z; Yi T; Lv Y
Front Endocrinol (Lausanne); 2023; 14():1233929. PubMed ID: 37766691
[TBL] [Abstract][Full Text] [Related]
6. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
7. The utility of sentinel Lymph node biopsy in the lateral neck in papillary thyroid carcinoma.
Yan XQ; Ma ZS; Zhang ZZ; Xu D; Cai YJ; Wu ZG; Zheng ZQ; Xie BJ; Cao FL
Front Endocrinol (Lausanne); 2022; 13():937870. PubMed ID: 35957824
[TBL] [Abstract][Full Text] [Related]
8. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study.
Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ
Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients.
Lu Y; Jiang L; Chen C; Chen H; Yao Q
Medicine (Baltimore); 2020 Apr; 99(15):e19795. PubMed ID: 32282744
[TBL] [Abstract][Full Text] [Related]
11. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
[TBL] [Abstract][Full Text] [Related]
12. Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.
Zhang X; Chen W; Fang Q; Fan J; Feng L; Guo L; Liu S; Ge H; Du W
Front Endocrinol (Lausanne); 2021; 12():716082. PubMed ID: 34335480
[TBL] [Abstract][Full Text] [Related]
13. Correlation analysis of risk factors for cervical lymphatic metastasis in papillary thyroid carcinoma.
Sun H; Zhao X; Wang X; Ma J; Liu M
Diagn Pathol; 2024 Jan; 19(1):13. PubMed ID: 38218832
[TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G
J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary study of superselective lymph node dissection in regional lateral cervical lymph node metastasis of papillary thyroid carcinoma].
Zhao BH; Huang ZH; Huang YC; Zhang XW; An CM; Niu LJ; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):484-489. PubMed ID: 33902212
[No Abstract] [Full Text] [Related]
16. [Risk factors analyses for lateral neck lymph node metastasis in papillary thyroid carcinoma].
Qi ZJ; Liu LF; Cheng L; Han X; Wang T; Li F; Lu C; Zhang AB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):603-606. PubMed ID: 31327195
[No Abstract] [Full Text] [Related]
17. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
Li X; Zhang H; Zhou Y; Cheng R
World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
[TBL] [Abstract][Full Text] [Related]
18. Risk factors analysis of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a retrospective study of 830 patients.
Zhong H; Zeng Q; Long X; Lai Y; Chen J; Wang Y
World J Surg Oncol; 2024 Jun; 22(1):162. PubMed ID: 38907249
[TBL] [Abstract][Full Text] [Related]
19. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract][Full Text] [Related]
20. Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis.
Li F; Zhou FJ; Zhu TW; Qiu HL; Zhang XT; Ruan BW; Huang DY
Adv Clin Exp Med; 2023 Jul; 32(7):753-761. PubMed ID: 36603142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]